Endurance Wealth Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$2K Hold
69
﹤0.01% 597
2023
Q1
$1K Hold
69
﹤0.01% 623
2022
Q4
$1K Hold
69
﹤0.01% 611
2022
Q3
$1K Hold
69
﹤0.01% 591
2022
Q2
$2K Hold
69
﹤0.01% 577
2022
Q1
$2K Hold
69
﹤0.01% 605
2021
Q4
$2K Hold
69
﹤0.01% 587
2021
Q3
$2K Hold
69
﹤0.01% 599
2021
Q2
$2K Hold
69
﹤0.01% 601
2021
Q1
$3K Hold
69
﹤0.01% 587
2020
Q4
$3K Hold
69
﹤0.01% 554
2020
Q3
$3K Hold
69
﹤0.01% 548
2020
Q2
$3K Hold
69
﹤0.01% 536
2020
Q1
$2K Buy
+69
New +$2.56K ﹤0.01% 508

Other funds holding FMS

Endurance Wealth Management's FMS Position: Q2 2023 in Review

Endurance Wealth Management held its Fresenius Medical Care (FMS) position steady in Q2 2023 at 69 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #597.

Endurance Wealth Management first reported a position in FMS in Q1 2020 and has held it in 14 quarters since. The position peaked at $3K in Q1 2021. 144 funds tracked by Wall St. Rank hold FMS as of Q2 2023.

  • Endurance Wealth Management held 69 shares of Fresenius Medical Care worth $2K as of Q2 2023.
  • Endurance Wealth Management left its Fresenius Medical Care share count unchanged in Q2 2023.
  • Fresenius Medical Care made up ﹤0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #597 holding.
  • Endurance Wealth Management first reported a position in Fresenius Medical Care in Q1 2020 and has held it in 14 quarters since.
  • Endurance Wealth Management's Fresenius Medical Care position peaked at $3K in Q1 2021.
  • 144 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2023.

Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.